Oxidase uncoupling in heme monooxygenases: Human cytochrome P450 CYP3A4 in Nanodiscs

被引:47
|
作者
Grinkova, Yelena V.
Denisov, Ilia G.
McLean, Mark A.
Sligar, Stephen G.
机构
[1] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Chem, Urbana, IL 61801 USA
关键词
Cytochrome P450; CYP3A4; Nanodiscs; P450; mechanism; Uncoupling; Oxidase pathway; LIVER MICROSOMAL CYTOCHROME-P-450; HIGH-VALENT IRON; OXYGEN ACTIVATION; LIGAND-BINDING; 3A4; COOPERATIVITY; KINETICS; HYDROXYLATION; INTERMEDIATE; OXIDATIONS;
D O I
10.1016/j.bbrc.2012.12.072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The normal reaction mechanism of cytochrome P450 operates by utilizing two reducing,equivalents to reduce atmospheric dioxygen, producing one molecule of water and an oxygenated product in an overall stoichiometry of 2 electrons:1 dioxygen:1 product. However, three alternate unproductive pathways exist where the intermediate iron-oxygen states in the catalytic cycle can yield reduced oxygen products without substrate metabolism. The first involves release of superoxide from the oxygenated intermediate while the second occurs after input of the second reducing equivalent. Superoxide rapidly dismutates and hence both processes produce hydrogen peroxide that can be cytotoxic to the organism. In both cases, the formation of hydrogen peroxide involves the same overall stoichiometry as oxygenases catalysis. The key step in the catalytic cycle of cytochrome P450 involves scission of the oxygen-oxygen bond of atmospheric dioxygen to produce a higher valent iron-oxo state termed "Compound I". This intermediate initiates a radical reaction in the oxygenase pathway but also can uptake two additional reducing equivalents from reduced pyridine nucleotide (NADPH) and the flavoprotein reductase to produce a second molecule of water. This non-productive decay of Compound I thus yields an overall oxygen to NADPH ratio of 1:2 and does not produce hydrocarbon oxidation. This water uncoupling reaction provides one of a limited means to study the reactivity of the critical Compound I intermediate in P450 catalysis. We measured simultaneously the rates of NADPH and oxygen consumption as a function of substrate concentration during the steady-state hydroxylation of testosterone catalyzed by human P450 CYP3A4 reconstituted in Nanodiscs. We discovered that the "oxidase" uncoupling pathway is also operating in the substrate free form of the enzyme with rate of this pathway substantially increasing with the first substrate binding event. Surprisingly, a large fraction of the reducing equivalents used by the P450 system is wasted in this oxidase pathway. In addition, the overall coupling with testosterone and bromocryptine as substrates is significantly higher in the presence of anionic lipids, which is attributed to the changes in the redox potential of CYP3A4 and reductase. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1223 / 1227
页数:5
相关论文
共 50 条
  • [41] Effects of cytochrome b5 on drug oxidation activities of human cytochrome P450 (CYP) 3As:: similarity of CYP3A5 with CYP3A4 but not CYP3A7
    Yamaori, S
    Yamazaki, H
    Suzuki, A
    Yamada, A
    Tani, H
    Kamidate, T
    Fujita, K
    Kamataki, T
    BIOCHEMICAL PHARMACOLOGY, 2003, 66 (12) : 2333 - 2340
  • [42] Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase
    Agrawal, Vishal
    Choi, Ji Ha
    Giacomini, Kathleen M.
    Miller, Walter L.
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (10): : 611 - 618
  • [43] The effects of type II binding on metabolic stability and binding affinity in cytochrome P450 CYP3A4
    Peng, Chi-Chi
    Pearson, Josh T.
    Rock, Dan A.
    Joswig-Jones, Carolyn A.
    Jones, Jeffrey P.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2010, 497 (1-2) : 68 - 81
  • [44] MEDI 202-Structural dynamics of the cooperative binding of organic molecules in the human Cytochrome P450 3A4 (CYP3A4)
    Fishelovitch, Dan
    Hazan, Carina
    Shaik, Sason
    Wolfson, Haim
    Nussinov, Ruth
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [45] Furocoumarins from grapefruit juice: A potent inhibitors of human cytochrome p450 isoenzymes CYP3A4 and CYP1B1
    Girennavar, B
    Poulose, SM
    Jayaprakasha, GK
    Pike, LM
    Patil, BS
    FASEB JOURNAL, 2006, 20 (04): : A572 - A572
  • [46] Recombinant Human Cytochrome P450 Monooxygenases for Drug Metabolite Synthesis
    Schroer, Kirsten
    Kittelmann, Matthias
    Luetz, Stephan
    BIOTECHNOLOGY AND BIOENGINEERING, 2010, 106 (05) : 699 - 706
  • [47] The cytochrome P450 4 (CYP4) family
    Simpson, AECM
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1997, 28 (03): : 351 - 359
  • [48] Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213 (vol 58, pg 1411, 2019)
    Denisov, Ilia G.
    Grinkova, Yelena V.
    Nandigrami, Prithviraj
    Shekhar, Mrinal
    Tajkhorshid, Emad
    Sligar, Stephen G.
    BIOCHEMISTRY, 2019, 58 (24) : 2796 - 2796
  • [49] Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes
    Kyoung-Ah Kim
    Ji-Young Park
    Ji-Suk Lee
    Sabina Lim
    Archives of Pharmacal Research, 2003, 26 : 631 - 637
  • [50] P450 humanized mice for the study of xenobiotics: CYP3A4 as a paradigm
    Granvil, CP
    Gonzalez, FJ
    FASEB JOURNAL, 2004, 18 (05): : A1201 - A1201